BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31737072)

  • 41. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.
    Wang X; He Y; Mackowiak B; Gao B
    Gut; 2021 Apr; 70(4):784-795. PubMed ID: 33127832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
    Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
    Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
    Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
    Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA expression profiling of male breast cancer.
    Fassan M; Baffa R; Palazzo JP; Lloyd J; Crosariol M; Liu CG; Volinia S; Alder H; Rugge M; Croce CM; Rosenberg A
    Breast Cancer Res; 2009; 11(4):R58. PubMed ID: 19664288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LINC00958 as new diagnostic and prognostic biomarker of childhood acute lymphoblastic leukaemia of B cells.
    Altieri F; Buono L; Lanzilli M; Mirabelli P; Cianflone A; Beneduce G; De Matteo A; Parasole R; Salvatore M; Smaldone G
    Front Oncol; 2024; 14():1388154. PubMed ID: 38884090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
    Cheng G
    Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer.
    Shen J; Jiang F
    Expert Opin Med Diagn; 2012 May; 6(3):197-207. PubMed ID: 22615714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The emerging role of microRNAs in resistance to lung cancer treatments.
    MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA and Epigenetics: Diagnostic and Therapeutic Opportunities.
    Monroig PD; Calin GA
    Curr Pathobiol Rep; 2013 Mar; 1(1):43-52. PubMed ID: 23515489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protocols for the Analysis of microRNA Expression, Biogenesis, and Function in Immune Cells.
    Zhang N; Hu G; Myers TG; Williamson PR
    Curr Protoc Immunol; 2019 Sep; 126(1):e78. PubMed ID: 31483103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment.
    Oh-Hohenhorst SJ; Lange T
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNAs and Potential Targets in Osteosarcoma: Review.
    Sampson VB; Yoo S; Kumar A; Vetter NS; Kolb EA
    Front Pediatr; 2015; 3():69. PubMed ID: 26380245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Review of Acute and Long-Term Neurological Complications Following Haematopoietic Stem Cell Transplant for Paediatric Acute Lymphoblastic Leukaemia.
    Gabriel M; Hoeben BAW; Uhlving HH; Zajac-Spychala O; Lawitschka A; Bresters D; Ifversen M
    Front Pediatr; 2021; 9():774853. PubMed ID: 35004543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges.
    Bernardo BC; Gregorevic P; Ritchie RH; McMullen JR
    Front Pharmacol; 2018; 9():1090. PubMed ID: 30298011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning.
    Zhang X; Li X; Wang C; Wang S; Zhuang Y; Liu B; Lian X
    Front Endocrinol (Lausanne); 2023; 14():1174911. PubMed ID: 37538797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR).
    Gordanpour A; Nam RK; Sugar L; Bacopulos S; Seth A
    J Vis Exp; 2012 May; (63):e3874. PubMed ID: 22643910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.